Somerset Medical Center’s Delayed Reporting of Suspected Poisonings and State-Level Escalation

Somerset Medical Center’s delayed reporting of suspected patient poisonings exposed a widening gap between recognizing dangerous incidents and acting on them. The dispute was not simply over whether patients had suffered unexplained harm: state rules required hospitals to report such events immediately, without waiting to establish their cause. Yet the hospital’s leadership initially chose to investigate internally before notifying outside authorities, and the state’s own response was also slowed by hesitation over whether foul play was plausible.

Background: A pattern without an explanation

The concern at Somerset Medical Center arose amid unusual patient events involving unexplained medication-related abnormalities. At a separate hospital, Saint Barnabas Hospital, investigators had found an IV bag positive for insulin, with needle marks around its perimeter; laboratory tests showed that patients experiencing unexplained crashes had unusually high levels of insulin, much of it introduced from outside the body. Those findings illustrate the kind of evidence that made unexplained patient events difficult to dismiss as ordinary clinical variation, although the Somerset incidents required their own investigation.

At Somerset, the accumulating incidents did not immediately produce a unified account. The book describes a reporting and investigative process that stalled or was diverted at several points, both inside the hospital and at the highest level of the New Jersey Department of Health and Senior Services. The difficulty was compounded by the distinction between identifying a troubling pattern and proving what had caused each individual patient’s condition. In a separate investigative obstacle, detectives were told that Pyxis retained medication-access data for only thirty days; Reverend Florian Gall had been dead nearly four times that long, and the hospital’s account left the relevant records apparently unavailable. The gap between a serious clinical signal and evidence usable in a criminal investigation therefore became part of the larger crisis.

Internal deliberations and the reporting rule

A meeting brought together Somerset Medical Center’s Risk Manager Mary Lund, Senior Vice President for Medical Affairs William Cors, Quality Manager Linda Vashed, Pharmacist Director Stuart Vigdor, and Pharmacist Nancy Doherty. The New Jersey Poison Control Center was represented by pharmacist Bruce Ruck and its director, Steven Marcus. This brought hospital risk management, medical leadership, pharmacy, and poison-control expertise into the same discussion, but it did not resolve who would take responsibility for escalating the incidents.

The applicable state regulation required hospitals to report events occurring within their facilities that jeopardized patients’ health and safety. The report was to be immediate; the hospital did not have to know the cause before reporting. That requirement matters because the uncertainty surrounding the incidents was not, under the rule described in the book, a reason to postpone notification. An internal inquiry could seek explanations, but it did not replace the duty to report.

The records also document the hospital’s position. In an email dated July 10, 2003, Marcus reported that the hospital’s risk manager, pharmacy director, chief operating officer, and chief medical officer had told him they did not plan to notify either the state health department or the police until after conducting a thorough investigation. The sequence placed the hospital’s internal review ahead of the external reporting that the regulation required to be immediate. Marcus separately contacted the Department of Health and Senior Services; a related note records that this occurred several hours before a further July 10 step at 4:23 p.m.

State response and continued delay

Marcus’s intervention did not produce an immediate, decisive state response. The Department of Health and Senior Services sent Edward Harbet, an investigator and registered nurse from its health-care systems analysis unit, to Somerset Medical Center on July 11 and again on July 14. Harbet reviewed the patients’ medical records and the hospital’s internal-investigation summary, and interviewed administrators. He could not identify specific findings that explained the relevant laboratory values. He told the administrators that others in his department would review the charts, leaving the assessment in progress rather than resolving the suspicion.

The state commissioner, Cliff Lacey, was informed of the incidents after Marcus and then hospital administrators reported them. Senior Assistant Commissioner Marilyn Dahl later wrote that Lacey considered it extremely premature to suspect foul play. Based on his experience with the drugs and as a senior medical officer at a large hospital, he could hypothesize scenarios that did not involve deliberate harm. Dahl said she had raised referring the matter to the Attorney General’s office, but Lacey declined. The state thus had information about the incidents and a proposed route for escalation, yet initially held back from taking it.

The fourth incident and escalation to the Attorney General

By September 26, 2003, concern within the Department of Health and Senior Services had intensified. Senior staff member Maureen F. Miller informed Dahl that the department knew of three unexplained incidents and was working with Somerset Medical Center’s administration, which was conducting an investigation. The hospital had now reported a fourth incident, however, and said it had occurred a month earlier—even though Somerset had been explicitly warned that any additional patient incidents had to be reported.

Dahl discussed the matter with Alison Gibson, director of Inspections, Compliance and Complaints, and Amie Thornton, assistant commissioner of Health Care Facility Quality. They agreed that there might be sufficient reason to suspect foul play. Their concern focused not only on the new incident but on the month-long delay in disclosing it after the earlier warning. They regarded the delay as irresponsible at best and sought permission to obtain legal advice about referring the matter to the Attorney General’s office.

That day, the Department of Health and Senior Services contacted the Attorney General’s office. Thornton also reported that Somerset Medical Center appeared to suspect foul play, having retained private investigators and attorneys. The hospital did not contact the Somerset County Prosecutor’s Office until seven days later. The order of events is significant: the state reached out to the Attorney General before the hospital itself approached county prosecutors.

Consequences and significance

The reporting dispute unfolded alongside a difficult transition from clinical anomalies to criminal investigation. Amy Loughren had already challenged a new insulin sign-out procedure, asking why insulin was being treated like a narcotic and pressing supervisors to explain what had happened. Her objections were not answered at the time. Later, police showed her Charles Cullen’s Pyxis activity from the night Reverend Florian Gall died. The printout unsettled her confidence in her friend; she could now imagine that he might have done something terrible, though she struggled to reconcile that possibility with the person she thought she knew.

Cooperating with investigators carried personal and professional risks for Loughren. Nurses feared that interviews could affect their jobs, rumors spread through the unit, and some colleagues avoided her because she was known as Cullen’s friend. She worried about her own position and whether the detectives might be mistaken, but went on to share paperwork and information, including the existence of Cerner patient records. Working with Tim Braun and Danny Baldwin gave her some relief from feeling alone, even as she remained exposed to the consequences of breaking rank.

The episode therefore tracks more than a delayed notification. It shows several separate thresholds—clinical recognition, hospital reporting, state assessment, and referral to law enforcement—at which action could be deferred while responsibility shifted between institutions and professional roles. The immediate-reporting rule was designed to prevent uncertainty from becoming a reason for silence; the chronology shows how internal review and official caution nevertheless extended the interval before the matter reached prosecutors. The eventual escalation did not erase those lost weeks, but it made the reporting failures themselves part of the story investigators and readers had to confront.